Biotech and Drug Stocks
7.45k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies.
Curated by Yahoo Finance
Follow this list to discover and track large drug and biotechnology companies. These companies develop specialty drugs and treatments for various diseases and medical conditions. Although there are risks associated with the success of the drug, those that succeed tend to have a strong series of earnings growth over a period of time, especially when they are backed by patents.
The list includes stocks priced at $5 or more with a three month average daily trading volume in excess of 200,000 shares. This list is generated daily and sorted by market cap; the gains are based on the latest closing price and limited to the top 30 stocks that meet the criteria.
This watchlist is similar to a discontinued watchlist called Battling Cancer.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the Global Financial Markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Performance
| Watchlist | Change Today | 1 Month Return | 1 Year Return | Total Return |
|---|---|---|---|---|
| Biotech and Drug Stocks | -0.26% | - | - | - |
| ^GSPC | +0.17% | +0.45% | +26.44% | +5515.79% |
31 Symbols
| Symbol | Company Name | Last Price | Change | % Change | Market Time | Volume | Avg Vol (3 month) | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and Company | 760 | -11.55 | -1.50% | 4:00 p.m. EDT | 2.03M | 2.90M | 722.31B |
| NVO | Novo Nordisk A/S | 128.42 | -0.24 | -0.19% | 4:00 p.m. EDT | 3.06M | 4.73M | 572.09B |
| JNJ | Johnson & Johnson | 149.91 | +0.06 | +0.04% | 4:00 p.m. EDT | 5.54M | 7.59M | 360.79B |
| MRK | Merck & Co., Inc. | 130.06 | -0.17 | -0.13% | 4:00 p.m. EDT | 5.72M | 8.21M | 329.42B |
| ABBV | AbbVie Inc. | 160.75 | +0.35 | +0.22% | 4:00 p.m. EDT | 3.40M | 5.69M | 283.86B |
| AZN | AstraZeneca PLC | 77.18 | -0.43 | -0.55% | 4:00 p.m. EDT | 3.57M | 6.01M | 239.29B |
| NVS | Novartis AG | 102.1 | +1.89 | +1.89% | 4:00 p.m. EDT | 1.82M | 1.60M | 208.33B |
| RHHBY | Roche Holding AG | 30.95 | +0.05 | +0.16% | 4:00 p.m. EDT | 1.52M | 2.78M | 197.89B |
| AMGN | Amgen Inc. | 310.15 | -2.71 | -0.87% | 4:00 p.m. EDT | 2.61M | 2.85M | 166.38B |
| PFE | Pfizer Inc. | 28.01 | -0.17 | -0.60% | 4:00 p.m. EDT | 25.50M | 42.71M | 158.72B |
| SNY | Sanofi | 49.28 | +0.59 | +1.21% | 4:00 p.m. EDT | 1.05M | 2.01M | 126.55B |
| VRTX | Vertex Pharmaceuticals Incorporated | 422.78 | +3.79 | +0.90% | 4:00 p.m. EDT | 1.06M | 1.04M | 109.10B |
| REGN | Regeneron Pharmaceuticals, Inc. | 973.8 | +5.80 | +0.60% | 4:00 p.m. EDT | 348.36k | 460.69k | 107.30B |
| GSK | GSK plc | 45.07 | +0.40 | +0.90% | 4:00 p.m. EDT | 3.63M | 3.34M | 92.71B |
| BMY | Bristol-Myers Squibb Company | 44.94 | +0.20 | +0.45% | 4:00 p.m. EDT | 8.62M | 15.42M | 91.10B |
| GILD | Gilead Sciences, Inc. | 65.96 | +1.38 | +2.14% | 4:00 p.m. EDT | 8.71M | 7.18M | 82.18B |
| ZTS | Zoetis Inc. | 169.04 | +0.91 | +0.54% | 4:00 p.m. EDT | 2.01M | 3.77M | 77.13B |
| MRNA | Moderna, Inc. | 117.31 | -5.38 | -4.39% | 4:00 p.m. EDT | 4.23M | 3.87M | 44.96B |
| TAK | Takeda Pharmaceutical Company Limited | 13.25 | -0.12 | -0.90% | 4:00 p.m. EDT | 1.95M | 1.67M | 41.58B |
| HLN | Haleon plc | 8.24 | -0.02 | -0.24% | 4:00 p.m. EDT | 3.48M | 6.15M | 37.63B |
| BIIB | Biogen Inc. | 221.5 | -1.25 | -0.56% | 4:00 p.m. EDT | 654.63k | 1.31M | 32.25B |
| BAYRY | Bayer Aktiengesellschaft | 7.81 | +0.01 | +0.13% | 3:59 p.m. EDT | 992.47k | 2.06M | 30.69B |
| ARGX | argenx SE | 374.63 | -7.92 | -2.07% | 4:00 p.m. EDT | 362.86k | 269.52k | 22.95B |
| BNTX | BioNTech SE | 91.67 | -0.39 | -0.42% | 4:00 p.m. EDT | 387.97k | 602.85k | 22.09B |
| ALNY | Alnylam Pharmaceuticals, Inc. | 150.47 | -0.90 | -0.59% | 4:00 p.m. EDT | 314.76k | 785.72k | 19.03B |
| GMAB | Genmab A/S | 28.84 | +0.03 | +0.10% | 4:00 p.m. EDT | 258.32k | 563.09k | 18.66B |
| TEVA | Teva Pharmaceutical Industries Limited | 16.25 | +0.25 | +1.56% | 4:00 p.m. EDT | 13.66M | 9.93M | 18.41B |
| BGNE | BeiGene, Ltd. | 161.13 | -7.51 | -4.45% | 4:00 p.m. EDT | 196.34k | 214.88k | 18.28B |
| ALPMY | Astellas Pharma Inc. | 9.72 | -0.18 | -1.82% | 3:59 p.m. EDT | 145.88k | 329.19k | 17.45B |
| RPRX | Royalty Pharma plc | 28.09 | +0.12 | +0.43% | 4:00 p.m. EDT | 2.85M | 2.85M | 16.78B |
- Yahoo Finance Video
Sanofi vaccine deal kicks off Novavax's 'new chapter': Analyst
Novavax (NVAX) shares are skyrocketing after the company announced a $1.2 billion deal with French drugmaker Sanofi (SNY). B. Riley Securities Managing Director & Group Head of Healthcare Research Mayank Mamtani joins Market Domination to break down the deal. The co-exclusive licensing agreement between the two pharmaceutical companies includes co-commercializing Novavax's COVID-19 vaccine and developing a combination vaccine for the flu and COVID-19. Mamtani highlights that the perception of Sanofi as rescuing Novavax during a post-pandemic struggle is "absolutely true, and it makes the company and the stock investable." He adds that the deal will mark a "new chapter" for Novavax. However, he warns of some of the realities the two companies will have to overcome to be successful. "In the past couple of years, we have completely misread how the vaccination uptake rates would look like," the analyst explains. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
- Yahoo Finance Video
Novavax-Sanofi vaccine deal, Yelp and Sweetgreen earnings: Morning Brief
On today's episode of The Morning Brief, Hosts Seana Smith and Brad Smith break down some of the biggest news affecting the market (^DJI, ^IXIC, ^GSPC). President Biden is reportedly set to release a new wave of tariffs targeting China in critical sectors, including electric vehicles, semiconductors, and solar equipment. Novavax (NVAX) shares skyrocket following the announcement of a $1.2 billion deal with Sanofi (SNY) to commercialize its combined COVID-19 and flu shot. Restaurant and business review platform Yelp (YELP) misses first-quarter earnings estimates as US consumer spending remains relatively weak. Taiwan Semiconductor (TSM) sales jumped nearly 60% year-over-year as the artificial intelligence race heats up and demand for chips rises. Wedbush Securities Managing Director Dan Ives joins Yahoo Finance to discuss "the fourth Industrial Revolution" in AI and Apple's (AAPL) position among other Big Tech competitors. Sweetgreen (SG) shares soar after topping first-quarter revenue expectations and raising its full-year guidance. CEO Jonathan Neman joins to discuss the company's plans moving forward. This post was written by Melanie Riehl
- Yahoo Finance Video
Stock markets, China tariffs, Novavax and Sanofi: 3 Things
The major stock market indexes (^DJI, ^IXIC, ^GSPC) are on the road to closing out the first full trading week of May on a high note, alongside several of its European counterparts: the FTSE 100 (^FTSE), the DAX Performance Index (^GDAXI), and the CAC 40 (^FCHI). President Biden is reportedly set to announce updates on Trump-era trade tariffs on China. Novavax (NVAX) shares are skyrocketing over 110% on news of the biotech company's plans to licensing deal with Sanofi (SNY, SAN.PA) to co-commercialize its COVID-19 vaccine For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
